Company intelligence / Profile preview

Apexus

United States

Ownership: Private
Development stage: Other

Overview

Apexus is the HRSA‑designated Prime Vendor for the U.S. 340B Drug Pricing Program, providing contracting, education, technical assistance, and other pharmacy solutions that improve access to medications and support compliant 340B operations for covered entities and manufacturers.[2][5][6]

Industry: Consulting

Partnerships

Health Resources and Services Administration (HRSA) – designated Prime Vendor for the 340B Drug Pricing ProgramManufacturers participating in 340B contractingPharmaceutical distributors participating in the 340B Prime Vendor Program networkCovered entities and 340B stakeholders (hospitals, health systems, clinics, contract pharmacies)

Beyond the preview

Go deeper on Apexus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apexus.

Explore the full profile